| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/20/2001 | CA2075183C Specimen test slide and method of testing for fecal occult blood |
| 03/20/2001 | CA2053254C Single-use disposable molten metal inclusion sensor |
| 03/15/2001 | WO2001018551A1 Method, reagent and test cartridge for determining clotting time |
| 03/15/2001 | WO2001018550A2 Determination of adrenomedullin-binding proteins |
| 03/15/2001 | WO2001018548A2 Protecting alkylating reagents used for quantifying homocysteine |
| 03/15/2001 | WO2001018547A1 Essential genes and assays relating thereto |
| 03/15/2001 | WO2001018546A2 Screening for inhibitors of 'paired helical filaments' |
| 03/15/2001 | WO2001018545A2 Method for identifying binding partners with position-specific arrays |
| 03/15/2001 | WO2001018544A1 Diagnosis, prognosis and treatment of trinucleotide repeat-associated diseases and intranuclear inclusions-associated diseases |
| 03/15/2001 | WO2001018543A1 Minimally invasive methods for measuring analytes in vivo |
| 03/15/2001 | WO2001018542A2 Identification, assessment, prevention, and therapy of ovarian cancer |
| 03/15/2001 | WO2001018541A1 Use of beta2gpi in diagnostic tests for autoimmune diseases |
| 03/15/2001 | WO2001018540A1 Systems for detecting analytes |
| 03/15/2001 | WO2001018539A2 Mixing chamber |
| 03/15/2001 | WO2001018538A2 Miscible liquid capacitive sensing system |
| 03/15/2001 | WO2001018537A2 Process for determining the acidity of a washing solution for fibres |
| 03/15/2001 | WO2001018531A1 Method for reducing costs associated with inebriation |
| 03/15/2001 | WO2001018530A1 Displacing volume in field of view |
| 03/15/2001 | WO2001018524A2 Methods for improving signal detection from an array |
| 03/15/2001 | WO2001018252A2 Methods for disease detection |
| 03/15/2001 | WO2001018246A1 Microfluidic and nanofluidic electronic devices for detecting changes in capacitance of fluids and methods of using |
| 03/15/2001 | WO2001018242A1 Affinity sensor for the detection of biological and/or chemical species and use thereof |
| 03/15/2001 | WO2001018240A2 Diagnostic and therapeutic methods in autoimmune disease |
| 03/15/2001 | WO2001018239A1 Sampling system |
| 03/15/2001 | WO2001018238A1 Compositions for the detection of enzyme activity in biological samples and methods of use thereof |
| 03/15/2001 | WO2001018237A1 Inactive enzymes as non-consuming sensors |
| 03/15/2001 | WO2001018235A2 Lateral flow device with metal oxide indicator and assay method employing same |
| 03/15/2001 | WO2001018234A1 Method to identify gene function using small molecule probes |
| 03/15/2001 | WO2001018216A2 26176, a novel calpain protease and uses thereof |
| 03/15/2001 | WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | WO2001018207A1 Human 7tm proteins receptors and polynucleotides encoding the same |
| 03/15/2001 | WO2001018206A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | WO2001018204A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | WO2001018198A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/15/2001 | WO2001018195A2 Luciferase expression cassettes and methods of use |
| 03/15/2001 | WO2001018193A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 03/15/2001 | WO2001018178A1 Nucleic acids and polypeptides of invertebrate bioamine transporter and methods of use |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018169A2 Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases |
| 03/15/2001 | WO2001018124A1 Red-emitting [8,9]benzophenoxazine nucleic acid dyes and methods for their use |
| 03/15/2001 | WO2001018059A2 Congener independent detection of microcystin and nodularin congeners |
| 03/15/2001 | WO2001018053A1 Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |
| 03/15/2001 | WO2001018050A2 T2r taste receptor family |
| 03/15/2001 | WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018047A1 Dendritic cell membrane protein fire |
| 03/15/2001 | WO2001018045A1 Crystal structure of a deacetylase and inhibitors thereof |
| 03/15/2001 | WO2001018042A2 Apoptosis proteins |
| 03/15/2001 | WO2001018035A2 Muc-1 derived peptides |
| 03/15/2001 | WO2001018022A1 52 human secreted proteins |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018018A1 Murf gene and enzyme ofpseudomonas aeruginosa |
| 03/15/2001 | WO2001018014A1 29 human cancer associated proteins |
| 03/15/2001 | WO2001017958A2 Neuropeptide sf receptor assays, compounds and therapeutic methods |
| 03/15/2001 | WO2001017670A1 Matrices of probes and their preparation |
| 03/15/2001 | WO2001017669A1 Method and device for applying a plurality of microdroplets onto a substrate |
| 03/15/2001 | WO2001017653A1 Systems and methods for separating blood in a rotating field |
| 03/15/2001 | WO2001017652A1 Blood processing systems and methods with sensors to detect contamination |
| 03/15/2001 | WO2001017650A1 Systems for sensing red blood cell hematocrit |
| 03/15/2001 | WO2001017649A1 Blood processing procedures with related sensing procedures |
| 03/15/2001 | WO2001017596A1 Method of treating cardio pulmonary diseases with no group compounds |
| 03/15/2001 | WO2001017532A1 Human neuropeptide receptor |
| 03/15/2001 | WO2001017343A1 Methods for evaluating a compound for its effect on skin |
| 03/15/2001 | WO2000077198A3 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/15/2001 | WO2000072005B1 Detection of wear-particles and other impurities in industrial or other fluids |
| 03/15/2001 | WO2000068362A3 Undifferentiated erythroid cells and their use in ligand binding assays |
| 03/15/2001 | WO2000061798A3 Method for mapping a dna molecule comprising an ad infinitum amplification step |
| 03/15/2001 | WO2000046402A8 Genomic analysis method |
| 03/15/2001 | WO2000044407A8 Materials and methods to inhibit hodgkin and reed sternberg cell growth |
| 03/15/2001 | WO2000028317A9 Improved non invasive measurement of blood flow parameters |
| 03/15/2001 | WO2000004382A8 Arrays of proteins and methods of use thereof |
| 03/15/2001 | WO1999054454A9 Mutants of the mycobacterium species and use of the same for screening for antibiotics vectors |
| 03/15/2001 | WO1999053076A9 Tao protein kinases and methods of use therefor |
| 03/15/2001 | DE19943861A1 Heizvorrichtung ohne Wood-Metall, die die Flüssigkeitsmessung nach Noack einer Flüssigkeitsprobe eines Petroleumproduktes, hauptsächlich eines Schmieröls, erlaubt und Verfahren unter Anwendung dieser Vorrichtung Wood-metal without heating device, the Noack a liquid sample of a petroleum product, especially a lubricating oil, allows the liquid and measurement method using this apparatus, |
| 03/15/2001 | DE19943813A1 Inducing and detecting various functional states in cells, organelles, viruses, molecular aggregates and biomolecules, comprises using a surface or medium with different binding properties at different sites |
| 03/15/2001 | DE19943743A1 Verfahren zur Identifizierung von Bindungspartnern mit positions-spezifischen Arrays A process for the identification of binding partners with position-specific arrays |
| 03/15/2001 | DE19941897A1 New deletion mutants of Interleukin-6 receptor protein useful for production of cell proliferation inhibitors for treatment of tumors, especially multiple myeloma |
| 03/15/2001 | DE19941447A1 Verfahren zur indirekten Bestimmung des Blutgerinnungsstatus Method for the indirect determination of coagulation |
| 03/15/2001 | DE19936618A1 Diagnostisches Kit und dessen Verwendung The diagnostic kit and its use |
| 03/15/2001 | DE19925668A1 Spleißosomprotein und seine Verwendung Spleißosomprotein and its use |
| 03/15/2001 | DE19925073A1 Nucleinsäuremoleküle mit spezifischer Erkennung von nativem PrP·S··c·, Herstellung und Verwendung Nucleic acid molecules with specific detection of native PrP c · S · · ·, production and use |
| 03/15/2001 | DE10035472A1 Komplex mit spezifischen dephosphorylierenden Enzymen, deren Effektoren und Verfahren zu ihrer Gewinnung Complex with specific dephosphorylating enzymes whose effectors and process for obtaining |
| 03/15/2001 | CA2848454A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2386607A1 Method for identifying binding partners with position-specific arrays |
| 03/15/2001 | CA2384777A1 T2r taste receptor family |
| 03/15/2001 | CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384663A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | CA2384650A1 Apoptosis proteins |
| 03/15/2001 | CA2384634A1 Human 7tm proteins receptors and polynucleotides encoding the same |
| 03/15/2001 | CA2384496A1 Luciferase expression cassettes and methods of use |
| 03/15/2001 | CA2384405A1 Dendritic cell membrane protein fire |
| 03/15/2001 | CA2384368A1 Method of detecting of screening cancer or precancer by determining the amount and integrity of nucleic acids |
| 03/15/2001 | CA2384146A1 Diagnosis, prognosis and treatment of trinucleotide repeat-associated diseases and intranuclear inclusions-associated diseases |
| 03/15/2001 | CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | CA2384083A1 Human neuropeptide receptor |
| 03/15/2001 | CA2384021A1 Compositions for the detection of enzyme activity in biological samples and methods of use thereof |
| 03/15/2001 | CA2384006A1 A minimal tau peptide for the nucleation of paired helical filaments |
| 03/15/2001 | CA2383885A1 Crystal structure of a deacetylase and inhibitors thereof |
| 03/15/2001 | CA2383800A1 52 human secreted proteins |